News

Filter

Current filters:

None

7901 to 7910 of 96529 results

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis

26-04-2012

US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Watson Pharma confirms buy of generic group Actavis for 4.25 billion euros

26-04-2012

As has been widely rumoured over this week, Watson Pharmaceuticals (NYSE: WPI) has confirmed a definitive…

ActavisGenericsMergers & AcquisitionsWatson Pharmaceuticals

GlaxoSmithKline net profits fall, but firm upbeat as sales grow

26-04-2012

Shares of UK pharma giant GlaxoSmithKline (LSE: GSK) fell 3% to £14.14 yesterday, after the company…

FinancialGlaxoSmithKlinePharmaceutical

Amgen acquires Turkish drugmaker Mustafa Nevzat for $700 million

26-04-2012

Global biotech giant Amgen (Nasdaq: AMGN) has reached agreement to acquire 95.6% of Mustafa Nevzat Pharmaceuticals…

AmgenBiotechnologyMergers & AcquisitionsMustafa Nevzat PharmaPharmaceutical

Bayer kicks off 2012 with 1st-qtr sales up 6.8% and profits rocketing 53.5%

26-04-2012

Germany's Bayer Group (BAYN: DE) saw its shares rise 2.3% to 54.41 in early trading this morning, after…

BayerFinancialPharmaceutical

Eli Lilly posts 1st-qtr sales and earnings down, but still beats forecasts

26-04-2012

US drug major Eli Lilly (NYSE: LLY) reported that first-quarter 2012 worldwide revenue declined 4% to…

Eli LillyFinancialPharmaceutical

Positive Ph III data for Biogen Idec's oral MS drug candidate BG-12

25-04-2012

US biotech firm Biogen Idec (Nasdaq: BIIB) says that detailed positive data from CONFIRM, the second…

Biogen IdecBiotechnologydimethyl fumarateNeurologicalResearch

7901 to 7910 of 96529 results

Parexel

Parexel

Back to top